ALKK–substudyA clinical trial designed to evaluate the pros of PTCA of an infarct-related-artery in asymptomatic patients after a recent myocardial infarction (MI); data was based on 300 patients at 22 centres in Germany.
Primary endpoint 1-year event-free survival.
Conclusion Percutaneous transluminal coronary angioplasty (PTCA) had a marginal benefit in stable survivors of acute MI.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.